Aaron Ciechanover, winner of the 2004 Nobel Prize for Chemistry, delivered a standing-room-only Distinguished Lecture at Georgia Tech in Atlanta on Oct. 4th on “Drug Development in the 21st Century: Are We Going to Cure All Diseases?”
Ciechanover, who is on the faculty of medicine at the Cancer and Vascular Biology Research Center at the Technion-Israel Institute of Technology, walked his audience through a history of formal drug development, from its origins in the 19th century up through the present. The future, Ciechanover said, will witness an era of health care that will be increasingly personal and predictive, using new tools like personal genome mapping to deliver drugs and health-maintenance regimens tailored to a single individual.
In 2004 Ciechanover shared the Nobel Prize for Chemistry with Professor Avram Hershko and Professor Irwin Rose for the discovery of ubiquitin-mediated protein degradation, a mechanism by which the cells of most living organisms cull unwanted proteins. In his lecture, Ciechanover was introduced by Georgia Tech’s College of Computing dean Zvi Galil who met the Nobel winner when Galil was serving as dean of Columbia University’s School of Engineering.
Ciechanover’s visit was co-sponsored by the College of Computing, the Emory University Center for AIDS Research, the American-Israel Chamber of Commerce, Southeast Region, the American-Israel Educational Institute, and Given Imaging.
“It was an honor for us to welcome Dr. Ciechanover to Atlanta and be a partner in this exceptional event. His brilliance and insights were a treat, and he is certainly one of Israel’s technological treasures,” said AICC Chairman Lorin Coles (Alliancesphere).
To view a video of the lecture, click here.